Active, Not Recruiting
Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS
NCT04957485
- Conditions
- DNA Virus Infections, Infections, Poxviridae Infections, +2 more
- Locations
-
- Meridian Clinical Research Omaha, Nebraska, United States
- Aventiv Research Inc Columbus, Ohio, United States